title: Structure-activity relationships for benzotriazine di-N-oxides.
abstract: SR 4233 (3-amino-1,2,4-benzotriazine 1,4-dioxide) is a bioreductive agent that selectively kills and radiosensitizes hypoxic mammalian cells in vitro and murine tumors in vivo. In an attempt to better understand the mechanism of action of the drug, and to determine whether a superior analog may exist, 15 benzotriazine-di-N-oxide analogs of SR 4233 have been evaluated to date for the following properties: hypoxic and aerobic toxicity toward CHO cells in vitro, drug-induced stimulation of oxygen consumption by incubation with respiration-inhibited cells, and acute LD50 evaluated in BALB/c mice. We noted several correlations between these biological properties of the drugs and some of their physicochemical characteristics. Both the hypoxic cytotoxicity and stimulation of oxygen consumption by respiration-inhibited cells were positively correlated with E1/2, the polarographic half-wave reduction potential, and a measure of electron affinity. The air-to-nitrogen differential cytotoxicity reached a maximum (corresponding to SR 4233) and then declined with increasing E1/2. The acute LD50 of each analog in mice decreased with increasing E1/2. One new compound, SR 4482, was found to be more toxic to hypoxic cells in vitro, but less toxic to mice, than SR 4233. It is similar in structure to SR 4233, but lacks any substituent in the 3-position of the triazine ring. This promising drug may represent a member of a new subseries of 1,2,4-benzotriazines with different structure-activity relationships.
authors.affiliation: Dept. of Radiation Oncology, Stanford University Medical Center, CA 94305.
authors.forename: E M
authors.initials: EM
authors.lastname: Zeman
authors.forename: M A
authors.initials: MA
authors.lastname: Baker
authors.forename: M J
authors.initials: MJ
authors.lastname: Lemmon
authors.forename: C I
authors.initials: CI
authors.lastname: Pearson
authors.forename: J A
authors.initials: JA
authors.lastname: Adams
authors.forename: J M
authors.initials: JM
authors.lastname: Brown
authors.forename: W W
authors.initials: WW
authors.lastname: Lee
authors.forename: M
authors.initials: M
authors.lastname: Tracy
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000633:toxicity; D002470:Cell Survival / Q000187:drug effects; D005260:Female; D007928:Lethal Dose 50; D051379:Mice; D008807:Mice, Inbred BALB C; D010100:Oxygen / Q000502:physiology; D010101:Oxygen Consumption / Q000187:drug effects; D013329:Structure-Activity Relationship; D000077704:Tirapazamine; D014227:Triazines / Q000494:pharmacology* / Q000633:toxicity
chemical_list: D000970:Antineoplastic Agents; D014227:Triazines; D000077704:Tirapazamine; D010100:Oxygen